Cover Image
Market Research Report
Product code
977303

Europe Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027

Published: | Data Bridge Market Research Private Limited | 160 Pages | Delivery time: 3-5 business days

Price

Back to Top
Europe Alopecia Treatment (Hair Loss) Market - Industry Trends and Forecast to 2027
Published: October 1, 2020
Data Bridge Market Research Private Limited
Content info: 160 Pages
Delivery time: 3-5 business days
  • ALL
  • Description
  • Table of Contents
Description

Europe alopecia treatment (hair loss) market is projected to register a CAGR of 6.1% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:

Europe Alopecia Treatment (Hair Loss) Market, By Disease Type (Non-Cicatricial Alopecia, Cicatricial Alopecia, Traction Alopecia and Others), Treatment (Localized Therapies, Systemic Therapies, Medical Devices and Herbal Treatment), Gender (Male and Female), Form (Oral, Topical and Parenteral), End User (Hospital, Home Healthcare and Dermatology Centers), Distribution Channel (Direct Tender, Retail Sales and Pharmacies), Country (U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland and Rest of Europe) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of Europe alopecia treatment (hair loss) market are:

Increase in prevalence of chemotherapy induced alopecia

Changing lifestyle

Market Players

The key market players for Europe alopecia treatment (hair loss) market are listed below:

Gerolymatos International SA

Follicum AB

Taisho Pharmaceutical Holdings Co., Ltd.

Vita-Cos-Med Klett-Loch GmbH

Vitabiotics Ltd.

WOCKHARDT

Ales Groupe

Teva Pharmaceuticals USA, Inc. (A Subsidiary of Teva Pharmaceuticals Industries Ltd.)

Pfizer Inc.

GlaxoSmithKline plc

Dr. Reddy's Laboratories Ltd.

Abbott

Johnson & Johnson Services, Inc

Cipla Inc.

Sun Pharmaceutical Industries Ltd.

Aurobindo Pharma

Perrigo Company plc

Viviscal Limited (A Subsidiary of Church & Dwight Co.)

Dr. Kurt Wolff GmbH & Co. KG

Labo International S.r.l.

Watermans

WON TECH Co., Ltd.

PureTech

Table of Contents

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET
  • 1.4 LIMITATIONS
  • 1.5 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 CURRENCY AND PRICING
  • 2.5 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.6 MULTIVARIATE MODELLING
  • 2.7 DISEASE TYPE OF ALOPECIA TREATMENT (HAIR LOSS) LIFELINE CURVE
  • 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.9 DBMR MARKET POSITION GRID
  • 2.10 MARKET TREATMENT COVERAGE GRID
  • 2.11 VENDOR SHARE ANALYSIS
  • 2.12 SECONDARY SOURCES
  • 2.13 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: REGULATIONS

5 EPIDERMOLOGY

6 PIPELINE ANALYSIS

7 IMPACT OF COVID 19 PANDEMIC ON THE MARKET

  • 7.1 PRICE IMPACT
  • 7.2 IMPACT ON SUPPLY CHAIN
  • 7.3 IMPACT ON DEMAND
  • 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS
  • 7.5 CONCLUSION

8 MARKET OVERVIEW

  • 8.1 DRIVERS
    • 8.1.1 INCREASE IN GERIATRIC POPULATION
    • 8.1.2 RISE IN PREVALENCE OF ALOPECIA CONDITIONS
    • 8.1.3 INCREASE IN PREVALENCE OF CHEMOTHERAPY INDUCED ALOPECIA
    • 8.1.4 INCREASING LEVEL OF STRESS
    • 8.1.5 CHANGING LIFESTYLES
  • 8.2 RESTRAINTS
    • 8.2.1 SIDE EFFECTS ASSOCIATED WITH THE AVAILABLE HAIR LOSS TREATMENT THERAPIES
    • 8.2.2 HIGH COST OF THERAPIES
    • 8.2.3 RECALL OF DRUG
  • 8.3 OPPORTUNITIES
    • 8.3.1 TECHNOLOGICAL ADVANCEMENTS IN HAIR TREATMENT MEDICAL DEVICES
    • 8.3.2 RISING DISPOSABLE INCOME
    • 8.3.3 STRATEGIC INITIATIVES BY THE MARKET PLAYERS
    • 8.3.4 INCREASING AWARENESS REGARDING THE ALOPECIA (HAIR LOSS)
  • 8.4 CHALLENGES
    • 8.4.1 PATENT EXPIRATION
    • 8.4.2 IMPROPER REIMBURSEMENT POLICIES
    • 8.4.3 EXISTENCE OF ALTERNATIVE TREATMENT OPTIONS

9 EUROPE ALOPECIATREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE

  • 9.1 OVERVIEW
  • 9.2 NON-CICATRICIAL ALOPECIA
    • 9.2.1 ANDROGENIC ALOPECIA
    • 9.2.2 ALOPECIA AREATA
    • 9.2.3 ALOPECIA UNIVERSALIS
    • 9.2.4 ANAGEN ARREST/ANAGEN EFFLUVIUM
    • 9.2.5 TELOGEN EFFLUVIUM
  • 9.3 TRACTION ALOPECIA
  • 9.4 CIATRICIAL ALOPECIA
    • 9.4.1 FRONTAL FIBROSING ALOPECIA
    • 9.4.2 FOLLICULITIS DECALVANS
    • 9.4.3 LICHEN PLANOPILARIS
  • 9.5 OTHERS

10 EUROPE ALOPECIATREATMENT (HAIR LOSS) MARKET, BY TREATMENT

  • 10.1 OVERVIEW
  • 10.2 LOCALIZED THERAPIES
    • 10.2.1 MINOXIDIL
    • 10.2.2 INTRALESIONAL CORTICOSTEROIDS
    • 10.2.3 TRIAMCINOLONE ACETONIDE
    • 10.2.4 HYDROCORTISONE ACETATE
    • 10.2.5 OTHERS
    • 10.2.6 TOPICAL CORTICOSTEROIDS
      • 10.2.6.1 Clobetasol Propionate
      • 10.2.6.2 Betamethasone Valerate
      • 10.2.6.3 Fluocinolone
      • 10.2.6.4 Dexamethasone
      • 10.2.6.5 Halcinonide
    • 10.2.7 FINASTERIDE
    • 10.2.8 ANTHRALIN
    • 10.2.9 TOPICAL IMMUNOTHERAPY
    • 10.2.10 MICRONUTRIENT SUPPLEMENTATION
      • 10.2.10.1 Vitamin A
      • 10.2.10.2 Vitamin D
      • 10.2.10.3 Iron
      • 10.2.10.4 Zinc
      • 10.2.10.5 Niacin
      • 10.2.10.6 Folic Acid
      • 10.2.10.7 Others
    • 10.2.11 OTHERS
  • 10.3 MEDICAL DEVICES
    • 10.3.1 LASER TREATMENT
      • 10.3.1.1 Hair Comb
      • 10.3.1.2 Wearable Laser Devices
      • 10.3.1.3 Cap
      • 10.3.1.4 Hair Band
      • 10.3.1.5 Helmet
      • 10.3.1.6 Machines
    • 10.3.2 HIGH POWER LED
    • 10.3.3 PHOTOTHERAPY
      • 10.3.3.1 Ultraviolet A-1
      • 10.3.3.2 Narrowband Ultraviolet B
  • 10.4 SYSTEMIC THERAPIES
    • 10.4.1 CORTICOSTEROIDS
    • 10.4.2 METHOTREXATE
    • 10.4.3 CYCLOSPORINE
    • 10.4.4 OTHERS
  • 10.5 HERBAL TREATMENT
    • 10.5.1 ALOE BARBADENSIS
    • 10.5.2 PHYLLANTHUS EMBELICA
    • 10.5.3 PRUNUS AMYGDALUS
    • 10.5.4 AVENA SATIVA
    • 10.5.5 AMARANTHUS SPINOSUS
    • 10.5.6 CAJANUS CAJAN
    • 10.5.7 DAUCUS CAROTA
    • 10.5.8 JUGLANS REGIA
    • 10.5.9 BACOPA MONNIERE
    • 10.5.10 MEDICAGO SATIVA
    • 10.5.11 LACTUCA SATIVA
    • 10.5.12 PELVETIA CANALICULATA
    • 10.5.13 OTHERS

11 EUROPE ALOPECIATREATMENT (HAIR LOSS) MARKET, BY GENDER

  • 11.1 OVERVIEW
  • 11.2 MALE
  • 11.3 FEMALE

12 EUROPE ALOPECIATREATMENT (HAIR LOSS) MARKET, BY FORM

  • 12.1 OVERVIEW
  • 12.2 TOPICAL
    • 12.2.1 CREAM
    • 12.2.2 SOLUTION
    • 12.2.3 OTHERS
  • 12.3 ORAL
    • 12.3.1 TABLET
    • 12.3.2 CAPSULES
    • 12.3.3 OTHERS
  • 12.4 PARENTERAL
    • 12.4.1 INTRAVENOUS
    • 12.4.2 INTRAMUSCULAR

13 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER

  • 13.1 OVERVIEW
  • 13.2 DERMATOLOGY CENTERS
  • 13.3 HOSPITALS
  • 13.4 HOME HEALTHCARE

14 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL

  • 14.1 OVERVIEW
  • 14.2 PHARMACIES
    • 14.2.1 OSPITAL
    • 14.2.2 RETAIL
    • 14.2.3 ONLINE
  • 14.3 RETAIL SALES
  • 14.4 DIRECT TENDER

15 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GEOGRAPHY

  • 15.1 EUROPE
    • 15.1.1 GERMANY
    • 15.1.2 FRANCE
    • 15.1.3 ITALY
    • 15.1.4 U.K.
    • 15.1.5 SPAIN
    • 15.1.6 NETHERLANDS
    • 15.1.7 RUSSIA
    • 15.1.8 SWITZERLAND
    • 15.1.9 TURKEY
    • 15.1.10 AUSTRIA
    • 15.1.11 NORWAY
    • 15.1.12 HUNGARY
    • 15.1.13 LITHUANIA
    • 15.1.14 IRELAND
    • 15.1.15 POLAND
    • 15.1.16 REST OF EUROPE

16 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, COMPANY LANDSCAPE

  • 16.1 COMPANY SHARE ANALYSIS: EUROPE

17 SWOT

18 COMPANY PROFILES

  • 18.1 JOHNSON & JOHNSON SERVICES, INC
    • 18.1.1 COMPANY SNAPSHOT
    • 18.1.2 REVENUE ANALYSIS
    • 18.1.3 COMPANY SHARE ANALYSIS
    • 18.1.4 PRODUCT PORTFOLIO
    • 18.1.5 RECENT DEVELOPMENTS
  • 18.2 GLAXOSMITHKLINE PLC
    • 18.2.1 COMPANY SNAPSHOT
    • 18.2.2 REVENUE ANALYSIS
    • 18.2.3 COMPANY SHARE ANALYSIS
    • 18.2.4 PRODUCT PORTFOLIO
    • 18.2.5 RECENT DEVELOPMENTS
  • 18.3 TAISHO PHARMACEUTICAL HOLDINGS CO., LTD.
    • 18.3.1 COMPANY SNAPSHOT
    • 18.3.2 REVENUE ANALYSIS
    • 18.3.3 COMPANY SHARE ANALYSIS
    • 18.3.4 PRODUCT PORTFOLIO
    • 18.3.5 RECENT DEVELOPMENTS
  • 18.4 MERCK SHARP & DOHME CORP. (A SUBSIDIARY OF MERCK & CO., INC.)
    • 18.4.1 COMPANY SNAPSHOT
    • 18.4.2 REVENUE ANALYSIS
    • 18.4.3 COMPANY SHARE ANALYSIS
    • 18.4.4 PRODUCT PORTFOLIO
    • 18.4.5 RECENT DEVELOPMENT
  • 18.5 SUN PHARMACEUTICAL INDUSTRIES LTD.
    • 18.5.1 COMPANY SNAPSHOT
    • 18.5.2 REVENUE ANALYSIS
    • 18.5.3 PRODUCT PORTFOLIO
    • 18.5.4 RECENT DEVELOPMENTS
  • 18.6 PFIZER INC.
    • 18.6.1 COMPANY SNAPSHOT
    • 18.6.2 REVENUE ANALYSIS
    • 18.6.3 PRODUCT PORTFOLIO
    • 18.6.4 RECENT DEVELOPMENTS
  • 18.7 ZYDUS PHARMACEUTICALS, INC. (A SUBSIDIARY OF ZYDUS CADILA)
    • 18.7.1 COMPANY SNAPSHOT
    • 18.7.2 REVENUE ANALYSIS
    • 18.7.3 PRODUCT PORTFOLIO
    • 18.7.4 RECENT DEVELOPMENTS
  • 18.8 PAR PHARMACEUTICAL (A SUBSIDIARY OF ENDO INTERNATIONAL PLC)
    • 18.8.1 COMPANY SNAPSHOT
    • 18.8.2 REVENUE ANALYSIS
    • 18.8.3 PRODUCT PORTFOLIO
    • 18.8.4 RECENT DEVELOPMENTS
  • 18.9 TEVA PHARMACEUTICALS USA, INC. (A SUBSIDIARY OF TEVA PHARMACEUTICALS INDUSTRIES LTD.)
    • 18.9.1 COMPANY SNAPSHOT
    • 18.9.2 REVENUE ANALYSIS
    • 18.9.3 PRODUCT PORTFOLIO
    • 18.9.4 RECENT DEVELOPMENTS
  • 18.10 CIPLA INC.
    • 18.10.1 COMPANY SNAPSHOT
    • 18.10.2 REVENUE ANALYSIS
    • 18.10.3 PRODUCT PORTFOLIO
    • 18.10.4 RECENT DEVELOPMENTS
  • 18.11 ALES GROUPE
    • 18.11.1 COMPANY SNAPSHOT
    • 18.11.2 PRODUCT PORTFOLIO
    • 18.11.3 RECENT DEVELOPMENTS
  • 18.12 AUROBINDO PHARMA
    • 18.12.1 COMPANY SNAPSHOT
    • 18.12.2 REVENUE ANALYSIS
    • 18.12.3 PRODUCT PORTFOLIO
    • 18.12.4 RECENT DEVELOPMENTS
  • 18.13 ABBOTT
    • 18.13.1 COMPANY SNAPSHOT
    • 18.13.2 REVENUE ANALYSIS
    • 18.13.3 PRODUCT PORTFOLIO
    • 18.13.4 RECENT DEVELOPMENTS
  • 18.14 CURALLUX, LLC.
    • 18.14.1 COMPANY SNAPSHOT
    • 18.14.2 PRODUCT PORTFOLIO
    • 18.14.3 RECENT DEVELOPMENTS
  • 18.15 DR. KURT WOLFF GMBH & CO. KG
    • 18.15.1 COMPANY SNAPSHOT
    • 18.15.2 BRAND PORTFOLIO
    • 18.15.3 RECENT DEVELOPMENTS
  • 18.16 DR. REDDY'S LABORATORIES LTD.
    • 18.16.1 COMPANY SNAPSHOT
    • 18.16.2 REVENUE ANALYSIS
    • 18.16.3 PRODUCT PORTFOLIO
    • 18.16.4 RECENT DEVELOPMENTS
  • 18.17 FREEDOM LASER THERAPY, INC.
    • 18.17.1 COMPANY SNAPSHOT
    • 18.17.2 PRODUCT PORTFOLIO
    • 18.17.3 RECENT DEVELOPMENTS
  • 18.18 FOLLICUM AB
    • 18.18.1 COMPANY SNAPSHOT
    • 18.18.2 PRODUCT PORTFOLIO
    • 18.18.3 RECENT DEVELOPMENTS
  • 18.19 GEROLYMATOS INTERNATIONAL SA
    • 18.19.1 COMPANY SNAPSHOT
    • 18.19.2 PRODUCT PORTFOLIO
    • 18.19.3 RECENT DEVELOPMENTS
  • 18.20 HCELL INC.
    • 18.20.1 COMPANY SNAPSHOT
    • 18.20.2 PRODUCT PORTFOLIO
    • 18.20.3 RECENT DEVELOPMENT
  • 18.21 IGROW LASER
    • 18.21.1 COMPANY SNAPSHOT
    • 18.21.2 PRODUCT PORTFOLIO
    • 18.21.3 RECENT DEVELOPMENTS
  • 18.22 LABO INTERNATIONAL S.R.L.
    • 18.22.1 COMPANY SNAPSHOT
    • 18.22.2 PRODUCT PORTFOLIO
    • 18.22.3 RECENT DEVELOPMENT
  • 18.23 LEXINGTON INTL., LLC.
    • 18.23.1 COMPANY SNAPSHOT
    • 18.23.2 PRODUCT PORTFOLIO
    • 18.23.3 RECENT DEVELOPMENTS
  • 18.24 NANOGEN
    • 18.24.1 COMPANY SNAPSHOT
    • 18.24.2 PRODUCT PORTFOLIO
    • 18.24.3 RECENT DEVELOPMENTS
  • 18.25 PERRIGO COMPANY PLC
    • 18.25.1 COMPANY SNAPSHOT
    • 18.25.2 REVENUE ANALYSIS
    • 18.25.3 PRODUCT PORTFOLIO
    • 18.25.4 RECENT DEVELOPMENTS
  • 18.26 PURETECH
    • 18.26.1 COMPANY SNAPSHOT
    • 18.26.2 REVENUE ANALYSIS
    • 18.26.3 PRODUCT PORTFOLIO
    • 18.26.4 RECENT DEVELOPMENTS
  • 18.27 VITABIOTICS LTD.
    • 18.27.1 COMPANY SNAPSHOT
    • 18.27.2 PRODUCT PORTFOLIO
    • 18.27.3 RECENT DEVELOPMENTS
  • 18.28 VITA-COS-MED KLETT-LOCH GMBH
    • 18.28.1 COMPANY SNAPSHOT
    • 18.28.2 PRODUCT PORTFOLIO
    • 18.28.3 RECENT DEVELOPMENT
  • 18.29 VIVISCAL LIMITED (A SUBSIDIARY OF CHURCH & DWIGHT CO.)
    • 18.29.1 COMPANY SNAPSHOT
    • 18.29.2 REVENUE ANALYSIS
    • 18.29.3 PRODUCT PORTFOLIO
    • 18.29.4 RECENT DEVELOPMENT
  • 18.30 WATERMANS
    • 18.30.1 COMPANY SNAPSHOT
    • 18.30.2 PRODUCT PORTFOLIO
    • 18.30.3 RECENT DEVELOPMENT
  • 18.31 WOCKHARDT
    • 18.31.1 COMPANY SNAPSHOT
    • 18.31.2 REVENUE ANALYSIS
    • 18.31.3 PRODUCT PORTFOLIO
    • 18.31.4 RECENT DEVELOPMENTS
  • 18.32 WON TECH CO., LTD.
    • 18.32.1 COMPANY SNAPSHOT
    • 18.32.2 PRODUCT PORTFOLIO
    • 18.32.3 RECENT DEVELOPMENTS

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF TABLES

  • TABLE 1 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, PIPELINE ANALYSIS
  • TABLE 2 INCIDENCE OF ALOPECIA ASSOCIATED TO THE MAIN CHEMOTHERAPIC DRUG CATEGORIES
  • TABLE 3 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE, 2018-2027 (USD MILLION)
  • TABLE 4 EUROPE NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 5 EUROPE NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 6 EUROPE TRACTION ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 7 EUROPE CIATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 8 EUROPE CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 9 EUROPE OTHERS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 10 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT, 2018-2027 (USD MILLION)
  • TABLE 11 EUROPE LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 12 EUROPE LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 13 EUROPE INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 14 EUROPE TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 15 EUROPE MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 16 EUROPE MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 17 EUROPE MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 18 EUROPE LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 19 EUROPE WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 20 EUROPE PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 21 EUROPE SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 22 EUROPE SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 23 EUROPE HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 24 EUROPE HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 25 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER, 2018-2027 (USD MILLION)
  • TABLE 26 EUROPE MALE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 27 EUROPE FEMALE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 28 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM, 2018-2027 (USD MILLION)
  • TABLE 29 EUROPE TOPICAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 30 EUROPE TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 31 EUROPE ORAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 32 NORTH AMERICA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 33 EUROPE PARENTERAL IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 34 EUROPE PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 35 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER, 2018-2027 (USD MILLION)
  • TABLE 36 EUROPE DERMATOLOGY CENTERS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 37 EUROPE HOSPITALS IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 38 EUROPE HOME HEALTHCARE IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 39 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL, 2018-2027 (USD MILLION)
  • TABLE 40 EUROPE PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 41 EUROPE PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 42 EUROPE RETAIL SALES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 43 EUROPE DIRECT TENDER IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY REGION, 2017-2027 (USD MILLION)
  • TABLE 44 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY COUNTRY, 2018-2027 (USD MILLION)
  • TABLE 45 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 46 EUROPE NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 47 EUROPE CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 48 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 49 EUROPE LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 50 EUROPE INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 51 EUROPE TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 52 EUROPE MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 53 EUROPE MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 54 EUROPE LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 55 EUROPE WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 56 EUROPE PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 57 EUROPE SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 58 EUROPE HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 59 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 60 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 61 EUROPE TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 62 EUROPE ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 63 EUROPE PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 64 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 65 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 66 EUROPE PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 67 GERMANY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 68 GERMANY NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 69 GERMANY CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 70 GERMANY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 71 GERMANY LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 72 GERMANY INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 73 ERMANY TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 74 GERMANY MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 75 GERMANY MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 76 GERMANY LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 77 GERMANY WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 78 GERMANY PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 79 GERMANY SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 80 ERMANY HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 81 GERMANY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 82 GERMANY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 83 GERMANY TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 84 GERMANY ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 85 GERMANY PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 86 GERMANY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 87 GERMANY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 88 GERMANY PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 89 FRANCE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 90 FRANCE NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 91 FRANCE CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 92 FRANCE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 93 FRANCE LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 94 FRANCE INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 95 FRANCE TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 96 FRANCE MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 97 FRANCE MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 98 FRANCE LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 99 FRANCE WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 100 FRANCE PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 101 FRANCE SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 102 FRANCE HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 103 FRANCE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 104 FRANCE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 105 FRANCE TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 106 FRANCE ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 107 FRANCE PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 108 FRANCE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 109 FRANCE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 110 FRANCE PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 111 ITALY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 112 ITALY NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 113 ITALY CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 114 ITALY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 115 ITALY LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 116 ITALY INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 117 ITALY TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 118 ITALY MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 119 ITALY MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 120 TALY LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 121 ITALY WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 122 ITALY PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 123 ITALY SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 124 TALY HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 125 ITALY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 126 ITALY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 127 ITALY TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 128 ITALY ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 129 ITALY PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 130 ITALY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 131 ITALY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 132 ITALY PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 133 U.K. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 134 U.K. NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 135 U.K. CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 136 U.K. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 137 U.K. LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 138 U.K. INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 139 U.K. TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 140 U.K. MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 141 U.K. MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 142 U.K. LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 143 U.K. WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 144 U.K. PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 145 U.K. SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 146 U.K. HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 147 U.K. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 148 U.K. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 149 U.K. TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 150 U.K. ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 151 U.K. PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 152 U.K. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 153 U.K. ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 154 U.K. PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 155 SPAIN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 156 SPAIN NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 157 SPAIN CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 158 SPAIN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 159 SPAIN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 160 SPAIN INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 161 SPAIN TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 162 SPAIN MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 163 SPAIN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 164 SPAIN LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 165 SPAIN WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 166 SPAIN PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 167 SPAIN SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 168 SPAIN HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 169 SPAIN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 170 SPAIN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 171 SPAIN TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 172 SPAIN ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 173 SPAIN PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 174 SPAIN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 175 SPAIN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 176 SPAIN PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 177 NETHERLANDS ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 178 NETHERLANDS NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 179 NETHERLANDS CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 180 NETHERLANDS ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 181 NETHERLANDS LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 182 NETHERLANDS INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 183 NETHERLANDS TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 184 NETHERLANDS MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 185 NETHERLANDS MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 186 NETHERLANDS LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 187 NETHERLANDS WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 188 NETHERLANDS PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 189 NETHERLANDS SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 190 NETHERLANDS HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 191 NETHERLANDS ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 192 NETHERLANDS ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 193 NETHERLANDS TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 194 NETHERLANDS ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 195 NETHERLANDS PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 196 NETHERLANDS ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 197 NETHERLANDS ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 198 NETHERLANDS PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 199 RUSSIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 200 RUSSIA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 201 RUSSIA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 202 RUSSIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 203 RUSSIA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 204 RUSSIA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 205 RUSSIA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 206 RUSSIA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 207 RUSSIA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 208 RUSSIA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 209 RUSSIA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 210 RUSSIA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 211 RUSSIA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 212 RUSSIA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 213 RUSSIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 214 RUSSIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 215 RUSSIA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 216 RUSSIA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 217 RUSSIA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 218 RUSSIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 219 RUSSIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 220 RUSSIA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 221 SWITZERLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 222 SWITZERLAND NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 223 SWITZERLAND CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 224 SWITZERLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 225 SWITZERLAND LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 226 SWITZERLAND INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 227 SWITZERLAND TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 228 SWITZERLAND MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 229 SWITZERLAND MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 230 SWITZERLAND LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 231 SWITZERLAND WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 232 SWITZERLAND PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 233 SWITZERLAND SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 234 SWITZERLAND HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 235 SWITZERLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 236 SWITZERLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 237 SWITZERLAND TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 238 SWITZERLAND ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 239 SWITZERLAND PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 240 SWITZERLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 241 SWITZERLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 242 SWITZERLAND PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 243 TURKEY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 244 TURKEY NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 245 TURKEY CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 246 TURKEY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 247 TURKEY LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 248 TURKEY INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 249 TURKEY TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 250 TURKEY MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 251 TURKEY MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 252 TURKEY LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 253 TURKEY WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 254 TURKEY PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 255 TURKEY SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 256 TURKEY HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 257 TURKEY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 258 TURKEY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 259 TURKEY TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 260 TURKEY ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 261 TURKEY PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 262 TURKEY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 263 TURKEY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 264 TURKEY PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 265 AUSTRIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 266 AUSTRIA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 267 AUSTRIA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 268 AUSTRIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 269 AUSTRIA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 270 AUSTRIA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 271 AUSTRIA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 272 AUSTRIA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 273 AUSTRIA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 274 AUSTRIA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 275 AUSTRIA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 276 AUSTRIA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 277 AUSTRIA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 278 AUSTRIA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 279 AUSTRIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 280 AUSTRIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 281 AUSTRIA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 282 AUSTRIA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 283 AUSTRIA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 284 AUSTRIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 285 AUSTRIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 286 AUSTRIA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 287 NORWAY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 288 NORWAY NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 289 NORWAY CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 290 NORWAY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 291 NORWAY LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 292 NORWAY INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 293 NORWAY TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 294 NORWAY MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 295 NORWAY MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 296 NORWAY LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 297 NORWAY WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 298 NORWAY PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 299 NORWAY SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 300 NORWAY HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 301 NORWAY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 302 NORWAY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 303 NORWAY TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 304 NORWAY ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 305 NORWAY PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 306 NORWAY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 307 NORWAY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 308 NORWAY PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 309 HUNGARY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 310 HUNGARY NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 311 HUNGARY CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 312 HUNGARY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 313 HUNGARY LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 314 HUNGARY INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 315 HUNGARY TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 316 HUNGARY MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 317 HUNGARY MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 318 HUNGARY LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 319 HUNGARY WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 320 HUNGARY PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 321 HUNGARY SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 322 HUNGARY HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 323 HUNGARY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 324 HUNGARY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 325 HUNGARY TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 326 HUNGARY ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 327 HUNGARY PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 328 HUNGARY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 329 HUNGARY ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 330 HUNGARY PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 331 LITHUANIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 332 LITHUANIA NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 333 LITHUANIA CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 334 LITHUANIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 335 LITHUANIA LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 336 LITHUANIA INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 337 LITHUANIA TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 338 LITHUANIA MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 339 LITHUANIA MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 340 LITHUANIA LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 341 LITHUANIA WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 342 LITHUANIA PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 343 LITHUANIA SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 344 LITHUANIA HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 345 LITHUANIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 346 LITHUANIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 347 LITHUANIA TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 348 LITHUANIA ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 349 LITHUANIA PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 350 LITHUANIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 351 LITHUANIA ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 352 LITHUANIA PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 353 IRELAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 354 IRELAND NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 355 IRELAND CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 356 IRELAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 357 IRELAND LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 358 IRELAND INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 359 IRELAND TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 360 IRELAND MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 361 IRELAND MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 362 IRELAND LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 363 IRELAND WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 364 IRELAND PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 365 IRELAND SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 366 IRELAND HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 367 IRELAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 368 IRELAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 369 IRELAND TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 370 IRELAND ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 371 IRELAND PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 372 IRELAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 373 IRELAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 374 IRELAND PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 375 POLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 376 POLAND NON-CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 377 POLAND CICATRICIAL ALOPECIA IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)
  • TABLE 378 POLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 379 POLAND LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 380 POLAND INTRALESIONAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 381 POLAND TOPICAL CORTICOSTEROIDS IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 382 POLAND MICRONUTRIENT SUPPLEMENTATION IN LOCALIZED THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 383 POLAND MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 384 POLAND LASER TREATMENT IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 385 POLAND WEARABLE LASER DEVICES IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 386 POLAND PHOTOTHERAPY IN MEDICAL DEVICES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 387 POLAND SYSTEMIC THERAPIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 388 POLAND HERBAL TREATMENT IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY TREATMENT 2018-2027 (USD MILLION)
  • TABLE 389 POLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY GENDER 2018-2027 (USD MILLION)
  • TABLE 390 POLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 391 POLAND TOPICAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 392 POLAND ORAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 393 POLAND PARENTERAL FORM IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY FORM 2018-2027 (USD MILLION)
  • TABLE 394 POLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY END USER 2018-2027 (USD MILLION)
  • TABLE 395 POLAND ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 396 POLAND PHARMACIES IN ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISTRIBUTION CHANNEL 2018-2027 (USD MILLION)
  • TABLE 397 REST OF EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET, BY DISEASE TYPE 2018-2027 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 2 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 3 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: DROC ANALYSIS
  • FIGURE 4 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: MULTIVARIATE MODELLING
  • FIGURE 7 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 8 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: DBMR MARKET POSITION GRID
  • FIGURE 9 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: MARKET TREATMENT COVERAGE GRID
  • FIGURE 10 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: VENDOR SHARE ANALYSIS
  • FIGURE 11 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: SEGMENTATION
  • FIGURE 12 INCREASE IN GERIATRIC POPULATION AND RISE IN PREVALENCE OF ALOPECIA CONDITIONS IS DRIVING THE EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 13 NON-CICATRICIAL ALOPECIA SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET IN 2020 & 2027
  • FIGURE 14 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET
  • FIGURE 15 ASIA-PACIFIC IS THE FASTEST GROWING MARKET FOR ALOPECIA TREATMENT (HAIR LOSS) MANUFACTURERS IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 16 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, 2019
  • FIGURE 17 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, 2019-2027 (USD MILLION)
  • FIGURE 18 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, CAGR (2020-2027)
  • FIGURE 19 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISEASE TYPE, LIFELINE CURVE
  • FIGURE 20 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, 2019
  • FIGURE 21 LOBAL ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, 2019-2027 (USD MILLION)
  • FIGURE 22 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, CAGR (2020-2027)
  • FIGURE 23 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TREATMENT, LIFELINE CURVE
  • FIGURE 24 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, 2019
  • FIGURE 25 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, 2019-2027 (USD MILLION)
  • FIGURE 26 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, CAGR (2020-2027)
  • FIGURE 27 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY GENDER, LIFELINE CURVE
  • FIGURE 28 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, 2019
  • FIGURE 29 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, 2019-2027 (USD MILLION)
  • FIGURE 30 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, CAGR (2020-2027)
  • FIGURE 31 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY FORM, LIFELINE CURVE
  • FIGURE 32 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, 2019
  • FIGURE 33 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, 2019-2027 (USD MILLION)
  • FIGURE 34 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, CAGR (2020-2027)
  • FIGURE 35 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY END USER, LIFELINE CURVE
  • FIGURE 36 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, 2019
  • FIGURE 37 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
  • FIGURE 38 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, CAGR (2020-2027)
  • FIGURE 39 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
  • FIGURE 40 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: SNAPSHOT (2019)
  • FIGURE 41 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2019)
  • FIGURE 42 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 43 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 44 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: BY TYPE (2020-2027)
  • FIGURE 45 EUROPE ALOPECIA TREATMENT (HAIR LOSS) MARKET: COMPANY SHARE 2019 (%)